These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 6775869

  • 1. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.
    Foegh M, Nicol K, Petersen IB, Schou G.
    Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869
    [Abstract] [Full Text] [Related]

  • 2. Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control.
    Føgh M, Corker CS, McLean H, Hunter WM, Petersen IB, Philip J, Schou G, Skakkebaek NE.
    Acta Endocrinol (Copenh); 1980 Oct; 95(2):251-7. PubMed ID: 6776755
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [Abstract] [Full Text] [Related]

  • 4. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC, Jouannet P, Marson J, Soumah A.
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF, Rollet J.
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [Abstract] [Full Text] [Related]

  • 6. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [Abstract] [Full Text] [Related]

  • 7. Use of low-dosage oral cyproterone acetate as a male contraceptive.
    Wang C, Yeung KK.
    Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
    [Abstract] [Full Text] [Related]

  • 8. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men.
    Pangkahila W.
    Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798
    [Abstract] [Full Text] [Related]

  • 9. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [Abstract] [Full Text] [Related]

  • 10. The effect of levonorgestrel and estrone rods on male reproductive function.
    Brache V, Alvarez-Sánchez F, León P, Schmidt F, Faundes A.
    Contraception; 1982 Jun; 25(6):591-603. PubMed ID: 6811196
    [Abstract] [Full Text] [Related]

  • 11. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 12. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [Abstract] [Full Text] [Related]

  • 13. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
    Bain J, Rachlis V, Robert E, Khait Z.
    Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
    [Abstract] [Full Text] [Related]

  • 14. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA, Yeung CH, Nieschlag E.
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 16. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS.
    J Clin Endocrinol Metab; 1992 Aug 15; 75(2):476-83. PubMed ID: 1639948
    [Abstract] [Full Text] [Related]

  • 17. Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate.
    Frick J, Danner C, Kunit G, Joos H, Köhle R.
    Int J Androl; 1982 Jun 15; 5(3):246-52. PubMed ID: 7118265
    [Abstract] [Full Text] [Related]

  • 18. The influence of pharmaceutical compounds on male fertility.
    Neumann F, Diallo FA, Hasan SH, Schenck B, Traore I.
    Andrologia; 1976 Jun 15; 8(3):203-35. PubMed ID: 793446
    [Abstract] [Full Text] [Related]

  • 19. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C.
    Hum Reprod; 1998 May 15; 13(5):1225-9. PubMed ID: 9647551
    [Abstract] [Full Text] [Related]

  • 20. Administration of norethandrolone and testosterone as a contraceptive agent for men.
    Brenner PF, Bernstein GS, Roy S, Jecht EW, Mishell DR.
    Contraception; 1975 Feb 15; 11(2):193-207. PubMed ID: 1112088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.